Ebola virus composition/vaccine
US9889188B1 · kind B1 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 2, 2016 |
| Grant date | Feb 13, 2018 |
| Priority date | — |
| Expiry date | Nov 2, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/14171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a composition and/or plasmid and/or vector vaccine which encodes four fragments of the GP1 Ebola protein attached to the extracellular domain of the potent immunostimulatory protein CD40 ligand, in the configuration of two compositions and/or vaccines that are mixed together, to respectively increase the levels of antibodies and CD8 effector T cells, against the lethal Ebola virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.